CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-23 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2020-06-23 | Halpin Michael Chief Operating Officer | Option exercise | +14,751 | $7.20 | $106K | 16,373 |
| 2020-06-23 | Halpin Michael Chief Operating Officer | Sale | −14,751 | $15.01 | $221K | 1,622 |
| 2020-06-23 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (right to buy) | −14,751 | 20,579 | ||
| 2020-06-16 | Halpin Michael Chief Operating Officer | Option exercise | +2,890 | $2.65 | $8K | 5,624 |
| 2020-06-16 | Halpin Michael Chief Operating Officer | Sale | −2,890 | $15.00 | $43K | 2,734 |
| 2020-06-16 | Halpin Michael Chief Operating Officer | Sale | −1,112 | $15.00 | $17K | 1,622 |
| 2020-06-16 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (right to buy) | −2,890 | 77,063 | ||
| 2020-05-08 | Colangelo Dominick President and CEO | Option exercise | +13,125 | $2.75 | $36K | 210,492 |
| 2020-05-08 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −13,125 | 65,625 | ||
| 2020-04-29 | ZERBE ROBERT L MD Director | Option exercise | +1,750 | 19,295 | ||
| 2020-04-29 | ZERBE ROBERT L MD Director | Option exercise · Restricted Stock Unit | −1,750 | 0 | ||
| 2020-04-29 | ZERBE ROBERT L MD Director | Grant or award · Restricted Stock Unit | +1,750 | 1,750 | ||
| 2020-04-29 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (right to buy) | +13,125 | 13,125 | ||
| 2020-04-29 | GILMAN STEVEN C Director | Option exercise | +1,750 | 1,750 | ||
| 2020-04-29 | GILMAN STEVEN C Director | Option exercise · Restricted Stock Unit | −1,750 | $14.56 | $25K | 0 |
| 2020-04-29 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +13,125 | 13,125 | ||
| 2020-04-29 | GILMAN STEVEN C Director | Grant or award · Restricted Stock Unit | +1,750 | 1,750 | ||
| 2020-04-29 | Hagen Heidi Director | Option exercise | +1,750 | 1,750 | ||
| 2020-04-29 | Hagen Heidi Director | Option exercise · Restricted Stock Unit | −1,750 | $14.56 | $25K | 0 |
Page 54 of 75 · 1,497 trades